SIM
RIGL icon

Spark Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Spark Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,460
Closed -$310K – 857
2016
Q3 		$310K Buy
8,460
+900
+12% +$25.8K 0.03% 579
2016
Q2 		$168K Sell
7,560
-24,310
-76% -$604K 0.02% 653
2016
Q1 		$662K Hold
31,870
– – 0.07% 382
2015
Q4 		$965K Buy
31,870
+620
+2% +$18.8K 0.12% 248
2015
Q3 		$768K Buy
31,250
+14,870
+91% +$444K 0.1% 297
2015
Q2 		$525K Hold
16,380
– – 0.07% 351
2015
Q1 		$584K Buy
16,380
+13,760
+525% +$377K 0.08% 335
2014
Q4 		$59K Buy
+2,620
New +$53K 0.01% 627

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Spark Investment Management's RIGL Position: Q4 2016 in Review

Spark Investment Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2016, closing a stake of 8,460 shares — an estimated $310K sold.

Spark Investment Management first reported a position in RIGL in Q4 2014 and held it in 8 quarters. The position peaked at $965K in Q4 2015. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

  • Spark Investment Management reported no remaining Rigel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Spark Investment Management sold 8,460 Rigel Pharmaceuticals shares in Q4 2016, an estimated $310K.
  • Spark Investment Management first reported a position in Rigel Pharmaceuticals in Q4 2014 and held it in 8 quarters.
  • Spark Investment Management's Rigel Pharmaceuticals position peaked at $965K in Q4 2015.
  • 107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on Spark Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.